Sudeep Pharma gets FDA nod for Gujarat plant
Sudeep Pharma Limited has received FDA approval for its new greenfield manufacturing facility located at 179 Nandesari, Gujarat. This approval authorizes the commencement of manufacturing operations at the site, which has an annual installed capacity of 51,200 MT. The facility will strengthen the company's manufacturing capabilities across Pharma, Food & Nutrition, and Specialty Ingredients segments. Commercial supplies are expected to begin in H2 FY27 after customer qualification. Approximately 60% of the capacity is allocated to existing portfolios, with the remainder for new product categories like phosphates, glycinates, gluconates, and citrates, including higher-value molecules such as bisglycinates. This expansion is anticipated to be a significant growth driver for the company.
Key Highlights
- FDA approval received for new pharma greenfield manufacturing facility in Gujarat.
- Facility boasts an annual installed capacity of 51,200 MT.
- Commercial supplies expected to commence in H2 FY27.
- Expansion to support growing demand in domestic and international markets.
- Capacity allocated for existing and new product categories, including high-value ingredients.
Price Impact
More from SUDEEPPHRM